Osimertinib Interactions
There are 615 drugs known to interact with osimertinib, along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 254 are major, 313 are moderate, and 48 are minor.
- View all 615 medications that may interact with osimertinib
- View osimertinib alcohol/food interactions (1)
- View osimertinib disease interactions (6)
Most frequently checked interactions
View interaction reports for osimertinib and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Activated Charcoal (charcoal)
- Adriamycin (doxorubicin)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Anti-D (RHO) Immunoglobulin (rho (d) immune globulin)
- Anusol (pramoxine/zinc oxide topical)
- AquADEKs (multivitamin with minerals)
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Atarax (hydroxyzine)
- Belsomra (suvorexant)
- Benadryl (diphenhydramine)
- Biotene Mouthwash (saliva substitutes topical)
- Celebrex (celecoxib)
- Cernevit (multivitamin)
- Childrens Chewable Multivitamins (multivitamin)
- Farxiga (dapagliflozin)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Fleet Enema (sodium biphosphate / sodium phosphate)
- Lipitor (atorvastatin)
- Metoprolol Tartrate (metoprolol)
- Omega-3 (omega-3 polyunsaturated fatty acids)
- Paracetamol (acetaminophen)
- Retinol (vitamin a topical)
- Vitamin B Complex 100 (multivitamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin K2 (menaquinone)
Osimertinib alcohol/food interactions
There is 1 alcohol/food interaction with osimertinib.
Osimertinib disease interactions
There are 6 disease interactions with osimertinib which include:
- cardiomyopathy
- dermatologic toxicities
- ocular disorders
- pulmonary toxicity
- QT prolongation
- renal/liver impairment
Report options
QR code containing a link to this page
More about osimertinib
- osimertinib consumer information
- Compare alternatives
- Reviews (41)
- Side effects
- Dosage information
- During pregnancy
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
